EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Merck's enterprise value is $251,050 Mil.
Merck's Revenue for the trailing twelve months (TTM) ended in Jun. 2022 was $57,169 Mil. Therefore, Merck's EV-to-Revenue for today is 4.39.
The historical rank and industry rank for Merck's EV-to-Revenue or its related term are showing as below:
MRK'
s EV-to-Revenue Range Over the Past 10 Years
Min: 2.02 Med: 4.28 Max: 6.28
Current: 4.4
During the past 13 years, the highest EV-to-Revenue of Merck was 6.28. The lowest was 2.02. And the median was 4.28.
MRK's EV-to-Revenue is ranked worse than 68.18% of 1034
companies
in the Drug Manufacturers industry
Industry Median: 2.64
vs MRK: 4.40
As of today (2022-08-16), Merck's stock price is $90.59.
Merck's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 was $22.53. Therefore, Merck's PS Ratio for today is 4.02.
Merck EV-to-Revenue Historical Data
The historical data trend for Merck's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Merck Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
EV-to-Revenue
4.01
4.85
6.04
5.33
4.49
Merck Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
EV-to-Revenue
4.90
4.47
4.49
4.27
4.42
Competitive Comparison
For the Drug Manufacturers - General subindustry, Merck's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merck EV-to-Revenue Distribution
For the Drug Manufacturers industry and Healthcare sector, Merck's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Merck's EV-to-Revenue falls into.
Merck's current Enterprise Value is $251,050 Mil.
Merck's Revenue for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $57,169 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merck's share price for today is $90.59.
Merck's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $22.53.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merck EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Merck's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.01(0.01%) Volume: 5,661,169 4:05PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:MRK has been successfully added to your 
